^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Soft Tissue Sarcoma
    Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    FDA
    Excerpt:
    Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated…for the treatment of:…metastatic soft tissue sarcoma, metastatic bone sarcomas…
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Soft tissue sarcoma: Other recommended regimens...doxorubicin